Rozanolixizumab
Drug timelines are a Plus or Pro feature.
23 regulatory and trial events tracked for Rozanolixizumab, covering 2022-04-04 to 2026-08-26. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Rozanolixizumab in Pediatric Study Participants With Moderate to Severe Generalized Myasthenia Gravis [Phase 2, Phase 3]